Articles

Study finds higher hospital admissions, complications, and mortality rates among patients with increased A1c.

Studies find greater risk reduction following treatment of patients with dyslipidemia.

Most important mediator due to changes in markers of plasma volume.

Secondary analysis evaluates effect of Women’s Health Initiative dietary intervention.

Guest Post by David Kliff, Editor, Diabetic Investor
Senseonics has taken their Eversense implantable CGM before an FDA panel, and Bigfoot has announced they have closed their series B $55 million financing round. The FDA has approved Dexcom’s G6 system, pushing shares in the company higher in early trading. And while they didn’t announce anything recently, our friends at Tandem are feeling the love as shares continue to surge higher in anticipation of their new system, which has low glucose suspend.

Additional conditions more likely in those diagnosed later in life.

Canagliflozin is found to have reduced risk of cardiovascular death or hospitalization due to heart failure in type 2 diabetes patients.

Use of high temperature, open flame for cooking both red meat and chicken associated with increased risk.

Study shows greater than 20% weight decrease, especially in men, can significantly increase risk of fragility fractures.

Mortality rates increased in adults with diabetes, low estimated glomerular filtration rate in absence of albuminuria.